Human immunodeficiency virus type 1 fitness and tropism: concept, quantification, and clinical relevance.

作者: M. Clementi , A. Lazzarin

DOI: 10.1111/J.1469-0691.2010.03335.X

关键词:

摘要: Two distinct aspects of human immunodeficiency virus type 1 (HIV-1) biopathology with important implications for the management treated patients have emerged during last decade: changes in relative viral fitness, and tropism. First, it has been observed that HIV-1 accumulates deleterious mutations leading to drug resistance different degrees reduction fitness antiretroviral therapy (ART). Although latter normally parallel a failure ART resulting from selection resistant mutants, drop replication capacity may be beneficial host. Moreover, specific antiviral compounds aimed at reducing could developed. Analysis determinants highly evolving populations shown extinction also obtained by forcing dynamic through increased (lethal) mutagenesis abolishes (violation error threshold). It great interest near future address this point strategies specifically planned molecular level. Furthermore, diagnostic evaluation limited master sequence low predictive value rapidly populations. These observations, together evidence all methodologies currently used analysis limitations, strongly suggest further research is warranted. This should use sensitive flexible technologies evaluate directly vivo or ex vivo, not only dominant but minority variants. Second, discovery two main co-receptors HIV-1, CCR5 CXCR4, led better understanding interaction envelope host cells development novel therapeutic agents inhibit entry. In perspective, tropism acquired major role.

参考文章(36)
Keith A. Crandall, The evolution of HIV Johns Hopkins University Press. ,(1999)
François Clavel, Esther Race, Fabrizio Mammano, HIV drug resistance and viral fitness. Advances in pharmacology (San Diego). ,vol. 49, pp. 41- 66 ,(2000) , 10.1016/S1054-3589(00)49023-X
M. Clementi, Perspectives and opportunities for novel antiviral treatments targeting virus fitness. Clinical Microbiology and Infection. ,vol. 14, pp. 629- 631 ,(2008) , 10.1111/J.1469-0691.2007.01937.X
R Namikawa, H Kaneshima, M Lieberman, I. Weissman, J. McCune, Infection of the SCID-hu mouse by HIV-1 Science. ,vol. 242, pp. 1684- 1686 ,(1988) , 10.1126/SCIENCE.3201256
Veronica Miller, Structured treatment interruptions in antiretroviral management of HIV-1. Current Opinion in Infectious Diseases. ,vol. 14, pp. 29- 37 ,(2001) , 10.1097/00001432-200102000-00006
M. Eigen, Error catastrophe and antiviral strategy Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 13374- 13376 ,(2002) , 10.1073/PNAS.212514799
Patrizia Bagnarelli, Manuela Vecchi, Nicoletta Burighel, Domenico Bellanova, Stefano Menzo, Massimo Clementi, Anita De Rossi, Genotypic and phenotypic correlates of the HIV Type 1 env gene evolution in infected children with discordant response to antiretroviral therapy. AIDS Research and Human Retroviruses. ,vol. 20, pp. 1306- 1313 ,(2004) , 10.1089/AID.2004.20.1306
E. Lazaro, C. Escarmis, J. Perez-Mercader, S. C. Manrubia, E. Domingo, Resistance of virus to extinction on bottleneck passages: Study of a decaying and fluctuating pattern of fitness loss Proceedings of the National Academy of Sciences of the United States of America. ,vol. 100, pp. 10830- 10835 ,(2003) , 10.1073/PNAS.1332668100
Enzo Boeri, Nicola Gianotti, Filippo Canducci, Hamid Hasson, Barbara Giudici, Antonella Castagna, Adriano Lazzarin, Massimo Clementi, Evolutionary characteristics of HIV type 1 variants resistant to protease inhibitors in the absence of drug-selective pressure. AIDS Research and Human Retroviruses. ,vol. 19, pp. 1151- 1153 ,(2003) , 10.1089/088922203771881257
Miguel E Quiñones-Mateu, Eric J Arts, Fitness of drug resistant HIV-1: methodology and clinical implications Drug Resistance Updates. ,vol. 5, pp. 224- 233 ,(2002) , 10.1016/S1368-7646(02)00123-1